Published in Nutr Metab (Lond) on January 31, 2008
Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative. Stroke (2014) 0.79
Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine. BMJ Open (2016) 0.75
Selenium in the Therapy of Neurological Diseases. Where is it Going? Curr Neuropharmacol (2016) 0.75
Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke (1989) 21.77
Inflammation in stroke and focal cerebral ischemia. Surg Neurol (2006) 2.85
Remodeling of cerebral arterioles in chronic hypertension. Hypertension (1989) 2.09
Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94
Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension (1993) 1.85
Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol (2001) 1.76
Potential new risk factors for ischemic stroke: what is their potential? Stroke (2006) 1.32
Dietary potassium intake and stroke mortality. Stroke (2000) 1.30
Nutritional factors for stroke and major cardiovascular diseases: international epidemiological comparison of dietary prevention. Health Rep (1994) 1.23
Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. Am J Physiol Regul Integr Comp Physiol (2001) 1.11
Myogenic and structural properties of cerebral arteries from the stroke-prone spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol (2003) 0.99
Potassium inhibits free radical formation. Hypertension (1994) 0.95
A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2006) 0.90
Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clin Exp Hypertens (2006) 0.86
Mechanisms that result in damage during and following cerebral ischemia. Neurosci Biobehav Rev (1997) 0.84
Potassium prevents death from strokes in hypertensive rats without lowering blood pressure. J Hypertens Suppl (1984) 0.84
The effects of potassium, magnesium, calcium, and fiber on risk of stroke. Nutr Rev (1999) 0.80
High-K diets reduce brain haemorrhage and infarcts, death rate and mesenteric arteriolar hypertrophy in stroke-prone spontaneously hypertensive rats. J Hypertens Suppl (1986) 0.80
Regulation of gene expression in the mammalian eye and its relevance to eye disease. Proc Natl Acad Sci U S A (2006) 2.91
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension (2005) 2.76
Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med (2012) 2.59
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J Am Soc Nephrol (2004) 2.59
Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev (2011) 2.22
Targets for vascular protection after acute ischemic stroke. Stroke (2004) 1.88
Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension (2006) 1.77
Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol (2007) 1.74
Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes (2005) 1.74
TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.73
Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol (2006) 1.63
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol (2005) 1.59
Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade. Hypertension (2005) 1.56
Endothelin activation of reactive oxygen species mediates stress-induced pressor response in Dahl salt-sensitive prehypertensive rats. Hypertension (2010) 1.49
Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension (2005) 1.49
Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats. J Hypertens (2002) 1.46
Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.35
NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension (2004) 1.31
Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Hypertension (2010) 1.30
Renal medullary ETB receptors produce diuresis and natriuresis via NOS1. Am J Physiol Renal Physiol (2008) 1.29
Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats. Hypertension (2008) 1.28
Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther (2005) 1.28
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. Am J Physiol Renal Physiol (2003) 1.27
The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol (2013) 1.25
Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol (2002) 1.24
Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension (2002) 1.24
Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide. Hypertension (2008) 1.24
Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Microvasc Res (2007) 1.23
Novel use of ultrasound to examine regional blood flow in the mouse kidney. Am J Physiol Renal Physiol (2009) 1.21
Early life stress sensitizes rats to angiotensin II-induced hypertension and vascular inflammation in adult life. Hypertension (2009) 1.21
Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens (2006) 1.17
Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats: a novel insight into vascular dysfunction. Hypertension (2008) 1.15
Flow regulation of collecting duct endothelin-1 production. Am J Physiol Renal Physiol (2010) 1.15
Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol (2003) 1.14
Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. Am J Physiol Heart Circ Physiol (2007) 1.14
Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension (2008) 1.13
Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. Am J Physiol Regul Integr Comp Physiol (2009) 1.11
Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2011) 1.10
Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension. Hypertension (2007) 1.10
Physiology of endothelin and the kidney. Compr Physiol (2011) 1.08
Functional role of ETB receptors in the renal medulla. Hypertension (2003) 1.08
Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure. Hypertension (2013) 1.07
Exaggerated cardiovascular stress responses and impaired beta-adrenergic-mediated pressor recovery in obese Zucker rats. Hypertension (2006) 1.07
Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet. Hypertension (2002) 1.06
Sex differences in renal medullary endothelin receptor function in angiotensin II hypertensive rats. Hypertension (2011) 1.06
Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension. Hypertension (2003) 1.05
Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases. Hypertension (2003) 1.05
Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet. Hypertension (2004) 1.03
Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury. Kidney Int (2010) 1.02
Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease. J Pharmacol Exp Ther (2011) 1.01
Altered nitric oxide synthase 3 distribution in mesenteric arteries of hypertensive rats. Hypertension (2002) 1.01
Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy (2005) 1.01
Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke. Microvasc Res (2009) 1.00
Chemerin connects fat to arterial contraction. Arterioscler Thromb Vasc Biol (2013) 0.99
Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Hypertension (2004) 0.99
Endothelin antagonists for diabetic and non-diabetic chronic kidney disease. Br J Clin Pharmacol (2013) 0.99
Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet. Am J Physiol Renal Physiol (2007) 0.98
Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity. Hypertension (2009) 0.97
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am J Physiol Regul Integr Comp Physiol (2005) 0.97
Early life stress downregulates endothelin receptor expression and enhances acute stress-mediated blood pressure responses in adult rats. Am J Physiol Regul Integr Comp Physiol (2010) 0.97
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br J Pharmacol (2005) 0.97
Endothelin, kidney disease, and hypertension. Hypertension (2013) 0.97
O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1. Hypertension (2009) 0.96
Plasma endothelin-1 release during acute stress: role of ethnicity and sex. Psychosom Med (2002) 0.96
Loss of renal medullary endothelin B receptor function during salt deprivation is regulated by angiotensin II. Am J Physiol Renal Physiol (2012) 0.95
Endothelin and NOS1/nitric oxide signaling and regulation of sodium homeostasis. Curr Opin Nephrol Hypertens (2008) 0.95
Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats. Exp Biol Med (Maywood) (2006) 0.94
Endothelin ET(B) receptors contribute to sex differences in blood pressure elevation in angiotensin II hypertensive rats on a high-salt diet. Clin Exp Pharmacol Physiol (2013) 0.94
Unique endothelin receptor binding in kidneys of ETB receptor deficient rats. Am J Physiol Regul Integr Comp Physiol (2003) 0.93
Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes Res (2004) 0.93
Selective and mixed endothelin receptor antagonism in cardiovascular disease. Trends Pharmacol Sci (2007) 0.93
Dissecting the genetic architecture of the cardiovascular and renal stress response. Biol Psychol (2002) 0.92
Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet. Am J Hypertens (2005) 0.92
Posttranslational regulation of NO synthase activity in the renal medulla of diabetic rats. Am J Physiol Renal Physiol (2004) 0.92
ETA receptor blockade attenuates hypertension and decreases reactive oxygen species in ETB receptor-deficient rats. J Cardiovasc Pharmacol (2004) 0.92
Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats. Clin Exp Pharmacol Physiol (2010) 0.92
Acute increases of renal medullary osmolality stimulate endothelin release from the kidney. Am J Physiol Renal Physiol (2006) 0.91
Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension (2005) 0.91
Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETA receptor. Am J Physiol Heart Circ Physiol (2004) 0.91
In vivo evidence for endothelin-1-mediated attenuation of alpha1-adrenergic stimulation. Am J Physiol Heart Circ Physiol (2005) 0.90
Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. Am J Physiol Heart Circ Physiol (2007) 0.90
A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2006) 0.90
Early life stress enhances angiotensin II-mediated vasoconstriction by reduced endothelial nitric oxide buffering capacity. Hypertension (2011) 0.90
Obesity-induced hypertension develops in young rats independently of the renin-angiotensin-aldosterone system. Exp Biol Med (Maywood) (2006) 0.90
Increaseed expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats. Am J Hypertens (2004) 0.89
Early life stress induces renal dysfunction in adult male rats but not female rats. Am J Physiol Regul Integr Comp Physiol (2012) 0.89
Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats. Am J Physiol Renal Physiol (2012) 0.89
Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo. Am J Physiol Renal Physiol (2008) 0.89
Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension. Am J Hypertens (2011) 0.89
Early life stress sensitizes the renal and systemic sympathetic system in rats. Am J Physiol Renal Physiol (2013) 0.87
Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats. Am J Physiol Gastrointest Liver Physiol (2009) 0.87
Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contraction. Am J Physiol Heart Circ Physiol (2011) 0.87
Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists. Am J Physiol Regul Integr Comp Physiol (2007) 0.87
Influence of salt on subcellular localization of nitric oxide synthase activity and expression in the renal inner medulla. Clin Exp Pharmacol Physiol (2007) 0.86
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension. Vascul Pharmacol (2006) 0.86
Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity. Hypertension (2003) 0.86
Sex differences in acute ANG II-mediated hemodynamic responses in mice. Am J Physiol Regul Integr Comp Physiol (2010) 0.85